nimodipine has been researched along with Injury, Ischemia-Reperfusion in 34 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Excerpt | Relevance | Reference |
---|---|---|
"The aim: To see whether nimodipine had neuroprotective effects in cerebral ischemia/reperfusion injury." | 8.12 | POTENTIAL PROTECTIVE EFFECTS OF NIMODIPINE FROM CEREBRAI ISCHEMIA REPERFUSION INJURY IN RATS. ( Al-Mudhafar, A; Fakharaldeen, Z; Hadi, N; Radhi, A, 2022) |
" The aim of the present study was to investigate effects of intraperitoneal administration of nimodipine on ischemia-reperfusion injury in ovaries." | 7.85 | Protective effects of intraperitoneal administration of nimodipine on ischemia-reperfusion injury in ovaries: Histological and biochemical assessments in a rat model. ( Behroozi-Lak, T; Farhad, N; Mohammadi, R; Moloody-Tapeh, M; Zarei, L, 2017) |
"To compare the individual effects of baicalin and jasminoidin with the combined effect of them on cerebral ischemia-reperfusion injury, and test whether the combined administration of baicalin and jasminoidin can improve the therapeutic effect." | 7.73 | A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. ( Li, P; Li, PT; Sun, ZH; Wang, YY; Wang, Z; Zhang, WS; Zhang, XJ; Zhang, ZJ, 2006) |
"The protective effect of the calcium channel blocker nimodipine on liver ischemia and reperfusion was studied in the rat." | 7.69 | Ischemia and reperfusion injury of the rat liver: the role of nimodipine. ( Calne, RY; Chávez-Cartaya, RE; Jamieson, NV; Pino DeSola, G; Ramirez-Romero, P, 1996) |
"Reperfusion injury is a pathophysiological entity distinct from the primary ischaemic injury; the oxygen arriving with blood recirculation, although necessary for alleviating the ischaemic status, may be harmful and provoke additional injury in the already damaged tissue." | 5.29 | Can nimodipine prevent ischaemic reperfusion injury in the rat brain? ( Albariño, AR; Carceller, F; Díez-Tejedor, E; Gutiérrez-Molina, M; López-Pajares, R; Roda, JM, 1993) |
"The aim: To see whether nimodipine had neuroprotective effects in cerebral ischemia/reperfusion injury." | 4.12 | POTENTIAL PROTECTIVE EFFECTS OF NIMODIPINE FROM CEREBRAI ISCHEMIA REPERFUSION INJURY IN RATS. ( Al-Mudhafar, A; Fakharaldeen, Z; Hadi, N; Radhi, A, 2022) |
" The aim of the present study was to investigate effects of intraperitoneal administration of nimodipine on ischemia-reperfusion injury in ovaries." | 3.85 | Protective effects of intraperitoneal administration of nimodipine on ischemia-reperfusion injury in ovaries: Histological and biochemical assessments in a rat model. ( Behroozi-Lak, T; Farhad, N; Mohammadi, R; Moloody-Tapeh, M; Zarei, L, 2017) |
"To compare the individual effects of baicalin and jasminoidin with the combined effect of them on cerebral ischemia-reperfusion injury, and test whether the combined administration of baicalin and jasminoidin can improve the therapeutic effect." | 3.73 | A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. ( Li, P; Li, PT; Sun, ZH; Wang, YY; Wang, Z; Zhang, WS; Zhang, XJ; Zhang, ZJ, 2006) |
"The protective effect of the calcium channel blocker nimodipine on liver ischemia and reperfusion was studied in the rat." | 3.69 | Ischemia and reperfusion injury of the rat liver: the role of nimodipine. ( Calne, RY; Chávez-Cartaya, RE; Jamieson, NV; Pino DeSola, G; Ramirez-Romero, P, 1996) |
"breviscapus on cerebral ischemia and its possible mechanism were discussed from the perspective of brain inflammatory pathway and intestinal CYP3A4, which depends on intestinal flora." | 1.91 | Effects of breviscapine on cerebral ischemia-reperfusion injury and intestinal flora imbalance by regulating the TLR4/MyD88/NF-κB signaling pathway in rats. ( Chen, HD; Jiang, MZ; Lai, Y; Lan, H; Li, X; Yang, WQ; Zhao, YY, 2023) |
"The animal model of cerebral infarction induced by Middle Cerebral Artery Occlusion (MCAO) was blocked by the suture method." | 1.56 | Protective Effect of Paeoniflorin on Acute Cerebral Infarction in Rats. ( Bao, X; Chen, Z; Feng, X; Ma, X; Qiu, C; Tao, X; Wu, W; Yang, J; Zhu, Q, 2020) |
"flower on cerebral ischemia-reperfusion injury in rats." | 1.51 | Protective effect of extract of the Camellia japonica L. on cerebral ischemia-reperfusion injury in rats. ( Lu, W; Wen, J; Xv, L, 2019) |
"Ischemia-reperfusion injury was induced by the four-vessel occlusion method and continued for 30 days." | 1.39 | The molecular and electrophysiological mechanism of buyanghuanwu decoction in learning and memory ability of vascular dementia rats. ( Hongbo, Z; Jinglong, T; Jun, L; Shasha, L; Tao, Q; Weijuan, G, 2013) |
"A rat model of cerebral ischemia and reperfusion injury was established using the middle cerebral artery occlusion (MCAO) model." | 1.38 | Effect of aloe polysaccharide on caspase-3 expression following cerebral ischemia and reperfusion injury in rats. ( Deng, YJ; Lu, JX; Lu, ZQ, 2012) |
"Rats were subjected to transient middle cerebral artery occlusion (MCAO) model using the intraluminal thread." | 1.35 | Total saponins of Panax notoginseng modulate the expression of caspases and attenuate apoptosis in rats following focal cerebral ischemia-reperfusion. ( Chen, BY; Deng, CQ; Li, H; Liang, Y; Luo, XG; Zhang, SP, 2009) |
"We describe subarachnoid hemorrhage (SAH) in a 66-year-old man, who underwent technically successful carotid stenting for a string-stenosis of the right internal carotid artery (ICA) in a presence of contralateral ICA occlusion with recurrent right hemisphere transient ischemic attacks." | 1.34 | Subarachnoid hemorrhage after carotid artery stenting. ( Kablak-Ziembicka, A; Moczulski, Z; Motyl, R; Pieniazek, P; Przewlocki, T; Tracz, W, 2007) |
"Nimodipine pretreatment (4 mg/kg, i." | 1.32 | Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats. ( Acharya, SB; Hota, D; Kumar, M; Rai, S; Yanpallewar, SU, 2004) |
"Reperfusion injury is a pathophysiological entity distinct from the primary ischaemic injury; the oxygen arriving with blood recirculation, although necessary for alleviating the ischaemic status, may be harmful and provoke additional injury in the already damaged tissue." | 1.29 | Can nimodipine prevent ischaemic reperfusion injury in the rat brain? ( Albariño, AR; Carceller, F; Díez-Tejedor, E; Gutiérrez-Molina, M; López-Pajares, R; Roda, JM, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.94) | 18.7374 |
1990's | 8 (23.53) | 18.2507 |
2000's | 10 (29.41) | 29.6817 |
2010's | 10 (29.41) | 24.3611 |
2020's | 5 (14.71) | 2.80 |
Authors | Studies |
---|---|
Chen, HD | 1 |
Jiang, MZ | 1 |
Zhao, YY | 1 |
Li, X | 1 |
Lan, H | 1 |
Yang, WQ | 1 |
Lai, Y | 1 |
Chen, H | 3 |
Chen, S | 3 |
Zhang, H | 3 |
Wang, S | 3 |
Li, Y | 5 |
Meng, X | 3 |
Fakharaldeen, Z | 1 |
Al-Mudhafar, A | 1 |
Radhi, A | 1 |
Hadi, N | 1 |
Wu, W | 1 |
Qiu, C | 1 |
Feng, X | 1 |
Tao, X | 1 |
Zhu, Q | 1 |
Chen, Z | 1 |
Ma, X | 1 |
Yang, J | 2 |
Bao, X | 1 |
Chen, X | 1 |
Yao, Z | 1 |
Peng, X | 1 |
Wu, L | 1 |
Wu, H | 1 |
Ou, Y | 1 |
Lai, J | 1 |
Lu, W | 1 |
Xv, L | 1 |
Wen, J | 1 |
Jinglong, T | 1 |
Weijuan, G | 1 |
Jun, L | 1 |
Tao, Q | 1 |
Hongbo, Z | 1 |
Shasha, L | 1 |
Chen, L | 1 |
Zhao, Y | 1 |
Zhang, T | 1 |
Dang, X | 1 |
Xie, R | 1 |
Li, Z | 2 |
Zhao, W | 1 |
Song, H | 1 |
Tang, H | 1 |
Tang, Y | 1 |
Li, N | 1 |
Shi, Q | 1 |
Guo, J | 1 |
Shang, E | 1 |
Duan, JA | 1 |
Wang, X | 1 |
Wang, C | 1 |
Yang, Y | 1 |
Ni, J | 1 |
Behroozi-Lak, T | 1 |
Zarei, L | 1 |
Moloody-Tapeh, M | 1 |
Farhad, N | 1 |
Mohammadi, R | 1 |
Li, H | 1 |
Deng, CQ | 1 |
Chen, BY | 1 |
Zhang, SP | 1 |
Liang, Y | 1 |
Luo, XG | 1 |
Babu, CS | 1 |
Ramanathan, M | 1 |
Li, J | 1 |
Lu, J | 1 |
Zhang, Y | 1 |
Zhu, Z | 1 |
Wan, H | 1 |
Mo, ZT | 1 |
Fang, YQ | 1 |
He, YP | 1 |
Zhang, S | 1 |
Lu, ZQ | 1 |
Deng, YJ | 1 |
Lu, JX | 1 |
Sobrado, M | 1 |
López, MG | 1 |
Carceller, F | 3 |
García, AG | 1 |
Roda, JM | 3 |
Yanpallewar, SU | 1 |
Hota, D | 1 |
Rai, S | 1 |
Kumar, M | 1 |
Acharya, SB | 1 |
Lin, XM | 1 |
Gong, PL | 1 |
Zeng, FD | 1 |
Du, GH | 1 |
Fu, YH | 1 |
Xu, J | 1 |
Zhang, JS | 1 |
Zhang, ZJ | 1 |
Li, P | 1 |
Wang, Z | 1 |
Li, PT | 1 |
Zhang, WS | 1 |
Sun, ZH | 1 |
Zhang, XJ | 1 |
Wang, YY | 1 |
Przewlocki, T | 1 |
Pieniazek, P | 1 |
Kablak-Ziembicka, A | 1 |
Motyl, R | 1 |
Moczulski, Z | 1 |
Tracz, W | 1 |
Fröba, G | 1 |
Bracht, H | 1 |
Hauser, B | 1 |
Chkhouta, AB | 1 |
Huber-Lang, M | 1 |
Rittirsch, D | 1 |
Brückner, UB | 1 |
Radermacher, P | 1 |
Schelzig, H | 1 |
Kaptanoglu, L | 1 |
Kapan, M | 1 |
Kapan, S | 1 |
Goksoy, E | 1 |
Oktar, H | 1 |
Díez-Tejedor, E | 2 |
Avendaño, C | 1 |
Gutiérrez-Molina, M | 1 |
López-Pajares, R | 1 |
Albariño, AR | 1 |
Stanimirovic, DB | 1 |
Micic, DV | 1 |
Markovic, M | 1 |
Spatz, M | 1 |
Mrsulja, BB | 1 |
Chávez-Cartaya, RE | 1 |
Pino DeSola, G | 1 |
Ramirez-Romero, P | 1 |
Calne, RY | 1 |
Jamieson, NV | 1 |
Rhee, RY | 1 |
Gloviczki, P | 1 |
Cambria, RA | 1 |
Lowell, RC | 1 |
Okazaki, H | 1 |
Ichihara, S | 1 |
Tsuda, Y | 1 |
Hosomi, N | 1 |
Kitadai, M | 1 |
Matsuo, H | 1 |
He, MX | 1 |
Ke, J | 1 |
Li, ZG | 1 |
Liu, FZ | 1 |
Kawaguchi, K | 1 |
Henshall, DC | 1 |
Simon, RP | 1 |
Liu, XD | 1 |
Pan, GY | 1 |
Xie, L | 1 |
Hou, YY | 1 |
Lan, W | 1 |
Su, Q | 1 |
Liu, GQ | 1 |
Prough, DS | 1 |
Furberg, CD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Study on the Treatment of Hypertensive Cerebral Hemorrhage With Panax Notoginseng Saponins[NCT02999048] | Phase 4 | 90 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
34 other studies available for nimodipine and Injury, Ischemia-Reperfusion
Article | Year |
---|---|
Effects of breviscapine on cerebral ischemia-reperfusion injury and intestinal flora imbalance by regulating the TLR4/MyD88/NF-κB signaling pathway in rats.
Topics: Animals; Brain Ischemia; Cytochrome P-450 CYP3A; Drugs, Chinese Herbal; Erigeron; Flavonoids; Gastro | 2023 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
N-methyl-D-aspartate receptor-mediated spinal cord ischemia-reperfusion injury and its protective mechanism.
Topics: Animals; Nimodipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2022 |
POTENTIAL PROTECTIVE EFFECTS OF NIMODIPINE FROM CEREBRAI ISCHEMIA REPERFUSION INJURY IN RATS.
Topics: Animals; Antioxidants; Brain Ischemia; Cerebral Infarction; Intercellular Adhesion Molecule-1; Inter | 2022 |
Protective Effect of Paeoniflorin on Acute Cerebral Infarction in Rats.
Topics: Acute Disease; Animals; Brain; Cerebral Infarction; Disease Models, Animal; Glucosides; Lipid Peroxi | 2020 |
Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF‑κB signaling pathway.
Topics: Animals; Apoptosis; Brain Ischemia; China; Flavones; Infarction, Middle Cerebral Artery; Inflammatio | 2020 |
Protective effect of extract of the Camellia japonica L. on cerebral ischemia-reperfusion injury in rats.
Topics: Animals; Brain Ischemia; Camellia; Disease Models, Animal; Female; Immunoglobulin G; L-Lactate Dehyd | 2019 |
The molecular and electrophysiological mechanism of buyanghuanwu decoction in learning and memory ability of vascular dementia rats.
Topics: Action Potentials; Animals; Apoptosis; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protei | 2013 |
Protective effect of Sheng-Nao-Kang decoction on focal cerebral ischemia-reperfusion injury in rats.
Topics: Abietanes; Animals; Brain Ischemia; Caffeic Acids; Caspase 3; Catechols; Dose-Response Relationship, | 2014 |
Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats.
Topics: Amino Acids; Animals; Antioxidants; Apigenin; Brain; Brain Injuries; Brain Ischemia; CA1 Region, Hip | 2014 |
New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Infarction, Middle Cerebral Artery; Interleukin-1 | 2017 |
Protective effects of intraperitoneal administration of nimodipine on ischemia-reperfusion injury in ovaries: Histological and biochemical assessments in a rat model.
Topics: Animals; Biomarkers; Calcium Channel Blockers; Female; Injections, Intraperitoneal; Nimodipine; Ovar | 2017 |
Total saponins of Panax notoginseng modulate the expression of caspases and attenuate apoptosis in rats following focal cerebral ischemia-reperfusion.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Caspase Inhibitors; Female; Infarction, Middle Cerebral A | 2009 |
Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics.
Topics: Animals; Behavior, Animal; Brain; Brain Ischemia; Calcium Channel Blockers; Glutamate-Ammonia Ligase | 2011 |
Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia.
Topics: Animals; Astragalus Plant; Cardiovascular Agents; Caspase 3; Disease Models, Animal; Drug Synergism; | 2012 |
β-Asarone protects PC12 cells against OGD/R-induced injury via attenuating Beclin-1-dependent autophagy.
Topics: Acorus; Allylbenzene Derivatives; Animals; Anisoles; Apoptosis Regulatory Proteins; Autophagy; Becli | 2012 |
Effect of aloe polysaccharide on caspase-3 expression following cerebral ischemia and reperfusion injury in rats.
Topics: Aloe; Animals; Brain Ischemia; Caspase 3; Cerebral Cortex; Gene Expression Regulation, Enzymologic; | 2012 |
Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia.
Topics: Animals; Apoptosis; Brain Ischemia; Calcium Channel Blockers; Cerebral Cortex; Cerebral Infarction; | 2003 |
Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats.
Topics: Animals; Brain; Carotid Artery, Common; Carotid Stenosis; Cerebrovascular Circulation; Escape Reacti | 2004 |
Effects of Gingko biloba extract on gap junction changes induced by reperfusion/reoxygenation after ischemia/hypoxia in rat brain.
Topics: Animals; Astrocytes; Brain Ischemia; Cell Communication; Cells, Cultured; Connexin 43; Gap Junctions | 2005 |
[Changes of expression of the P38 MAPK and caspase-3 in rat retinal ischemia-reperfusion model and the influence of Nimodipine].
Topics: Animals; Calcium Channel Blockers; Caspase 3; Female; Male; Nimodipine; p38 Mitogen-Activated Protei | 2006 |
A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury.
Topics: Analysis of Variance; Animals; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; Caspase 3; | 2006 |
Subarachnoid hemorrhage after carotid artery stenting.
Topics: Aged; Carotid Artery, Internal; Carotid Stenosis; Headache; Humans; Infusions, Intravenous; Ischemic | 2007 |
Effects of intrarenal administration of the calcium antagonist nimodipine during porcine aortic occlusion-induced ischemia/reperfusion injury.
Topics: Animals; Aorta; Apoptosis; Calcium; Calcium Channel Blockers; Cyclin-Dependent Kinase Inhibitor p21; | 2008 |
Effects of nimodipine and pentoxyfylline in prevention of hepatic ischemic damage in rats at normal and hypothermic conditions.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Calcium Channel Blockers; Hypothermia; L | 2008 |
Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia.
Topics: Animals; Blood Pressure; Brain Edema; Calcium Channel Blockers; Carotid Artery, External; Cerebral A | 1995 |
Can nimodipine prevent ischaemic reperfusion injury in the rat brain?
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Evoked Potentials, Somatosensory; Nimodipine | 1993 |
'Therapeutic window's for multiple drug treatment of experimental cerebral ischemia in gerbils.
Topics: 2-Amino-5-phosphonovalerate; Animals; Drug Therapy, Combination; Gerbillinae; Ischemic Attack, Trans | 1994 |
Ischemia and reperfusion injury of the rat liver: the role of nimodipine.
Topics: Animals; Calcium Channel Blockers; Hemoglobins; Ischemia; Liver; Liver Circulation; Male; Microcircu | 1996 |
The effects of nimodipine on ischemic injury of the spinal cord during thoracic aortic cross-clamping.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Constriction; Dogs; Hyperemia; Laser-Doppler Flo | 1996 |
Nimodipine improves brain energy metabolism and blood rheology during ischemia and reperfusion in the gerbil brain.
Topics: Animals; Brain; Calcium Channel Blockers; Cerebrovascular Circulation; Drug Evaluation, Preclinical; | 1996 |
Effects of nimodipine on acute cerebral ischemia and reperfusion injury of rats.
Topics: Animals; Biogenic Monoamines; Brain Ischemia; Calcium Channel Blockers; Cerebral Cortex; Electroence | 1996 |
Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.
Topics: Animals; Blood Glucose; Blood Pressure; Body Temperature; Brain; Calcium Channel Blockers; Dose-Resp | 1999 |
Cyclosporin A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Ischemia; Calcium Channel Bl | 2002 |
Nimodipine and the "no-reflow phenomenon"--experimental triumph, clinical failure?
Topics: Cerebrovascular Circulation; Heart Arrest; Humans; Nimodipine; Reperfusion Injury | 1989 |